The role of membrane transporters in cellular resistance to anticancer nucleoside drugs.
about
FUN26 (function unknown now 26) protein from saccharomyces cerevisiae is a broad selectivity, high affinity, nucleoside and nucleobase transporter.Bone marrow stromal cells modulate mouse ENT1 activity and protect leukemia cells from cytarabine induced apoptosisNucleoside transporter subtype expression and function in rat skeletal muscle microvascular endothelial cellsImexon enhances gemcitabine cytotoxicity by inhibition of ribonucleotide reductase.DNA repair mechanisms in cancer development and therapyStearoyl gemcitabine nanoparticles overcome resistance related to the over-expression of ribonucleotide reductase subunit M1.Molecular profile of 5-fluorouracil pathway genes in colorectal carcinoma.Polymeric nanogel formulations of nucleoside analogs.ABCC4 Is a Determinant of Cytarabine-Induced Cytotoxicity and Myelosuppression.Genetic factors influencing cytarabine therapy.Uptake carriers and oncology drug safety.Imatinib-resistant CML cells have low ENT activity but maintain sensitivity to gemcitabine.Resistance of leukemia cells to cytarabine chemotherapy is mediated by bone marrow stroma, involves cell-surface equilibrative nucleoside transporter-1 removal and correlates with patient outcome.The human equilibrative nucleoside transporter 1 mediates in vitro cytarabine sensitivity in childhood acute myeloid leukaemia.Polymorphisms at microRNA binding sites of Ara-C and anthracyclines-metabolic pathway genes are associated with outcome of acute myeloid leukemia patients.Nucleobase and Nucleoside Analogues: Resistance and Re-Sensitisation at the Level of Pharmacokinetics, Pharmacodynamics and Metabolism
P2860
Q27936958-C8245AEB-E449-4669-9A9C-5CB5450C70AFQ28483881-FB24AB6F-A038-44C0-ACD5-A760C3640BE6Q28570384-3D35BFF9-359B-4A32-AC17-0478C560BF71Q34329957-3DB6FEA8-019F-49D1-89B5-1E8AEAB62758Q35531287-879A8745-93CC-40DC-A168-75E90603C121Q35610203-9816F65D-9F9D-4D96-B507-BBF73ABE8882Q36161868-9B847662-FC1D-414B-BD5B-E3F02F2792D9Q36668023-22156D3F-F623-4669-AD5A-EE3530191B82Q36998913-0587CA54-9F05-4137-8608-5CAEEF37EC76Q37618228-79E2BE71-2665-406B-8D32-56959A09884AQ37663396-3F59E52F-9BC2-4817-9195-748BEA613C07Q39965234-68018EA0-1F05-4E3F-8CA6-10F2F32991C2Q41816813-1B04CCEC-435D-4170-9D4B-8D3ABAE9C3BFQ42725619-C5798AF9-146B-491D-960A-C3DF042F2639Q47137275-2EC0EA79-695B-4B45-8AEE-665D34172D85Q57175017-1DD440A8-94F6-4D04-9FC7-913BAA79EF6D
P2860
The role of membrane transporters in cellular resistance to anticancer nucleoside drugs.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
The role of membrane transporters in cellular resistance to anticancer nucleoside drugs.
@ast
The role of membrane transporters in cellular resistance to anticancer nucleoside drugs.
@en
The role of membrane transporters in cellular resistance to anticancer nucleoside drugs.
@nl
type
label
The role of membrane transporters in cellular resistance to anticancer nucleoside drugs.
@ast
The role of membrane transporters in cellular resistance to anticancer nucleoside drugs.
@en
The role of membrane transporters in cellular resistance to anticancer nucleoside drugs.
@nl
prefLabel
The role of membrane transporters in cellular resistance to anticancer nucleoside drugs.
@ast
The role of membrane transporters in cellular resistance to anticancer nucleoside drugs.
@en
The role of membrane transporters in cellular resistance to anticancer nucleoside drugs.
@nl
P2093
P1476
The role of membrane transporters in cellular resistance to anticancer nucleoside drugs
@en
P2093
Carol E Cass
James D Young
Marilyn L Clarke
Stephen A Baldwin
P356
10.1007/978-1-4615-1173-1_2
P577
2002-01-01T00:00:00Z